down arrow

Kerala Ayurveda

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE817B01025
  • NSEID:
  • BSEID: 530163
INR
339.85
-0.15 (-0.04%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 3.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Venus Remedies
Lyka Labs
Zenotech Lab.
Brooks Lab.
Kerala Ayurveda
Mankind Pharma
Valiant Laborato
Why is Kerala Ayurveda Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate -3.45% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
  • The company has been able to generate a Return on Capital Employed (avg) of 5.75% signifying low profitability per unit of total capital (equity and debt)
2
Flat results in Dec 24
  • PAT(Q) At Rs -2.89 cr has Fallen at -538.4% (vs previous 4Q average)
  • OPERATING PROFIT TO INTEREST (Q) Lowest at -2.77 times
  • PBDIT(Q) Lowest at Rs -1.19 cr.
3
With ROCE of 8, it has a Very Expensive valuation with a 5 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 30.34%, its profits have risen by 157.3% ; the PEG ratio of the company is 2.7
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kerala Ayurveda for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Kerala Ayurveda
30.34%
0.58
52.16%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.90%
EBIT Growth (5y)
-3.45%
EBIT to Interest (avg)
0.79
Debt to EBITDA (avg)
19.77
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.02
Tax Ratio
36.29%
Dividend Payout Ratio
0
Pledged Shares
13.36%
Institutional Holding
0.04%
ROCE (avg)
5.91%
ROE (avg)
10.70%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
409
Industry P/E
33
Price to Book Value
11.35
EV to EBIT
97.14
EV to EBITDA
56.75
EV to Capital Employed
5.04
EV to Sales
4.00
PEG Ratio
2.68
Dividend Yield
NA
ROCE (Latest)
7.99%
ROE (Latest)
7.32%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
PAT(Latest six months)

Higher at Rs 0.52 cr

NET SALES(Q)

Highest at Rs 31.13 cr

DEBT-EQUITY RATIO(HY)

Lowest at 1.77 times

-9What is not working for the Company
PAT(Q)

At Rs -2.89 cr has Fallen at -538.4% (vs previous 4Q average

OPERATING PROFIT TO INTEREST (Q)

Lowest at -2.77 times

PBDIT(Q)

Lowest at Rs -1.19 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -3.82%

PBT LESS OI(Q)

Lowest at Rs -2.34 cr.

EPS(Q)

Lowest at Rs -2.40

Loading Valuation Snapshot...
Here's what is working for Kerala Ayurveda
Net Sales - Quarterly
Highest at Rs 31.13 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 1.77 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Kerala Ayurveda
Profit After Tax (PAT) - Quarterly
At Rs -2.89 cr has Fallen at -538.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 0.66 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Lowest at -2.77 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -1.19 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at -3.82%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -2.34 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs -2.40
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)